Matches in SemOpenAlex for { <https://semopenalex.org/work/W2158106343> ?p ?o ?g. }
- W2158106343 endingPage "42" @default.
- W2158106343 startingPage "127" @default.
- W2158106343 abstract "Aim of this study was to evaluate and compare, by means of dynamic and static PET/CT, the distribution patterns and pharmacokinetics of fluorine-18 fluorodeoxyglucose ((18)F-FDG) and of fluorine-18-fluoromisonidazole ((18)F-FMISO) in non-small cell lung cancer (NSCLC) patients scheduled for intensity modulated radiation therapy (IMRT). Thirteen patients suffering from inoperable stage III NSCLC underwent PET/CTs with (18)F-FDG and (18)F-FMISO for tumor metabolism and hypoxia assessment accordingly. Evaluation of PET/CT studies was based on visual analysis, semi-quantitative (SUV) calculations and absolute quantitative estimations, after application of a two-tissue compartment model and a non-compartmental approach. (18)F-FDG PET/CT revealed all thirteen primary lung tumors as sites of increased (18)F-FDG uptake. Six patients demonstrated also in total 43 (18)F-FDG avid metastases; these patients were excluded from radiotherapy. (18)F-MISO PET/CT demonstrated 12/13 primary lung tumors with faint tracer uptake. Only one tumor was clearly (18)F-FMISO avid, (SUVaverage = 3.4, SUVmax = 5.0). Mean values for (18)F-FDG, as derived from dPET/CT data, were SUVaverage = 8.9, SUVmax = 15.1, K1 = 0.23, k2 = 0.53, k3 = 0.17, k4 = 0.02, influx = 0.05 and fractal dimension (FD) = 1.25 for the primary tumors. The respective values for (18)F-FMISO were SUVaverage = 1.4, SUVmax = 2.2, K1 = 0.26, k2 = 0.56, k3 = 0.06, k4 = 0.06, influx = 0.02 and FD = 1.14. No statistically significant correlation was observed between the two tracers. (18)F-FDG PET/CT changed therapy management in six patients, by excluding them from planned IMRT. (18)F-FMISO PET/CT revealed absence of significant tracer uptake in the majority of the (18)F-FDG avid NSCLCs. Lack of correlation between the two tracers' kinetics indicates that they reflect different molecular mechanisms and implies the discordance between increased glycolysis and hypoxia in the malignancy." @default.
- W2158106343 created "2016-06-24" @default.
- W2158106343 creator A5008622761 @default.
- W2158106343 creator A5010632119 @default.
- W2158106343 creator A5013804417 @default.
- W2158106343 creator A5039515006 @default.
- W2158106343 creator A5044583234 @default.
- W2158106343 creator A5048441129 @default.
- W2158106343 creator A5072329706 @default.
- W2158106343 creator A5075140211 @default.
- W2158106343 creator A5078003238 @default.
- W2158106343 creator A5089940123 @default.
- W2158106343 date "2015-01-01" @default.
- W2158106343 modified "2023-10-14" @default.
- W2158106343 title "Combined use of (18)F-FDG and (18)F-FMISO in unresectable non-small cell lung cancer patients planned for radiotherapy: a dynamic PET/CT study." @default.
- W2158106343 cites W1587146634 @default.
- W2158106343 cites W1619631706 @default.
- W2158106343 cites W1766290423 @default.
- W2158106343 cites W1833829642 @default.
- W2158106343 cites W1890605084 @default.
- W2158106343 cites W1908513134 @default.
- W2158106343 cites W1970547072 @default.
- W2158106343 cites W1973870205 @default.
- W2158106343 cites W1979538859 @default.
- W2158106343 cites W1980675667 @default.
- W2158106343 cites W1990402611 @default.
- W2158106343 cites W2000029267 @default.
- W2158106343 cites W2005719624 @default.
- W2158106343 cites W2007074692 @default.
- W2158106343 cites W2007074796 @default.
- W2158106343 cites W2032158647 @default.
- W2158106343 cites W2036622441 @default.
- W2158106343 cites W2044190493 @default.
- W2158106343 cites W2047284752 @default.
- W2158106343 cites W2063040188 @default.
- W2158106343 cites W2074960820 @default.
- W2158106343 cites W2083732963 @default.
- W2158106343 cites W2093573845 @default.
- W2158106343 cites W2094129713 @default.
- W2158106343 cites W2097598171 @default.
- W2158106343 cites W2099499650 @default.
- W2158106343 cites W2102954422 @default.
- W2158106343 cites W2107806932 @default.
- W2158106343 cites W2118170166 @default.
- W2158106343 cites W2124496728 @default.
- W2158106343 cites W2142616933 @default.
- W2158106343 cites W2143000781 @default.
- W2158106343 cites W2150499465 @default.
- W2158106343 cites W2156508634 @default.
- W2158106343 cites W2162505221 @default.
- W2158106343 cites W2164045422 @default.
- W2158106343 cites W2164987635 @default.
- W2158106343 cites W2166769518 @default.
- W2158106343 cites W2292187888 @default.
- W2158106343 cites W2339934527 @default.
- W2158106343 cites W4256222744 @default.
- W2158106343 cites W4297939389 @default.
- W2158106343 cites W2128254903 @default.
- W2158106343 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4396010" @default.
- W2158106343 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25973334" @default.
- W2158106343 hasPublicationYear "2015" @default.
- W2158106343 type Work @default.
- W2158106343 sameAs 2158106343 @default.
- W2158106343 citedByCount "15" @default.
- W2158106343 countsByYear W21581063432015 @default.
- W2158106343 countsByYear W21581063432016 @default.
- W2158106343 countsByYear W21581063432018 @default.
- W2158106343 countsByYear W21581063432019 @default.
- W2158106343 countsByYear W21581063432021 @default.
- W2158106343 countsByYear W21581063432022 @default.
- W2158106343 crossrefType "journal-article" @default.
- W2158106343 hasAuthorship W2158106343A5008622761 @default.
- W2158106343 hasAuthorship W2158106343A5010632119 @default.
- W2158106343 hasAuthorship W2158106343A5013804417 @default.
- W2158106343 hasAuthorship W2158106343A5039515006 @default.
- W2158106343 hasAuthorship W2158106343A5044583234 @default.
- W2158106343 hasAuthorship W2158106343A5048441129 @default.
- W2158106343 hasAuthorship W2158106343A5072329706 @default.
- W2158106343 hasAuthorship W2158106343A5075140211 @default.
- W2158106343 hasAuthorship W2158106343A5078003238 @default.
- W2158106343 hasAuthorship W2158106343A5089940123 @default.
- W2158106343 hasConcept C121608353 @default.
- W2158106343 hasConcept C126322002 @default.
- W2158106343 hasConcept C126838900 @default.
- W2158106343 hasConcept C199374082 @default.
- W2158106343 hasConcept C2775842073 @default.
- W2158106343 hasConcept C2776256026 @default.
- W2158106343 hasConcept C2777415128 @default.
- W2158106343 hasConcept C2777714996 @default.
- W2158106343 hasConcept C2779013556 @default.
- W2158106343 hasConcept C2780283643 @default.
- W2158106343 hasConcept C2989005 @default.
- W2158106343 hasConcept C509974204 @default.
- W2158106343 hasConcept C71924100 @default.
- W2158106343 hasConceptScore W2158106343C121608353 @default.
- W2158106343 hasConceptScore W2158106343C126322002 @default.
- W2158106343 hasConceptScore W2158106343C126838900 @default.
- W2158106343 hasConceptScore W2158106343C199374082 @default.